NMR structural analysis of MC1R-targeted rhenium(I) metallopeptides and biological evaluation of 99mTc(I) congeners

Organometallics

Volumn 31, Issue 16, 2012, Pages 5929-5939

  Morais, Maurício ^a   Raposinho, Paula D ^a   Oliveira, Maria Cristina ^a   Pantoja Uceda, David ^b   Jiménez, Maria Angeles ^b   Santos, Isabel ^a   Correia, João D G ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b INSTITUTO DE QUÍMICA FÍSICA ROCASOLANO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING AFFINITIES; BIOLOGICAL EVALUATION; CELL INTERNALIZATION; CHELATING UNITS; COMPETITIVE BINDING; CYCLIC PEPTIDES; IN-VIVO; MELANOMA CELLS; METALATIONS; METALLOPEPTIDES; MOLECULAR TARGETS; MOUSE MODELS; ORGANOMETALLIC PRECURSORS; PEPTIDE MOIETY; STRUCTURAL FEATURE; TARGETED RADIONUCLIDE THERAPIES;

BINDING ENERGY; CHELATION; DERMATOLOGY; NITROGEN OXIDES; ONCOLOGY; ORGANOMETALLICS; RHENIUM; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; STRUCTURAL ANALYSIS;

PEPTIDES;

EID: 84865486287     PISSN: 02767333     EISSN: 15206041     Source Type: Journal    
DOI: 10.1021/om300502n     Document Type: Article

References (44)

1. Correia, J. D.; Paulo, A.; Raposinho, P. D.; Santos, I. Radiometallated peptides for molecular imaging and targeted therapy Dalton Trans. 2011, 40 (23) 6144-6167
2. Reubi, J. C.; Maecke, H. R. Peptide-based probes for cancer imaging J. Nucl. Med. 2008, 49 (11) 1735-1738
3. Jemal, A.; Siegel, R.; Xu, J. Q.; Ward, E. Cancer Statistics Ca-Cancer J. Clin. 2010, 60 (5) 277-300
4. Lee, S.; Xie, J.; Chen, X. Peptide-based probes for targeted molecular imaging Biochemistry 2010, 49 (7) 1364-1376
5. Miao, Y.; Quinn, T. P. Peptide-targeted radionuclide therapy for melanoma Crit. Rev. Oncol. Hematol. 2008, 67 (3) 213-228
6. Gray-Schopfer, V.; Wellbrock, C.; Marais, R. Melanoma biology and new targeted therapy Nature 2007, 445 (7130) 851-857
7. Carlson, J. A.; Slominski, A.; Linette, G. P.; Mihm, M. C., Jr.; Ross, J. S. Biomarkers in melanoma: staging, prognosis and detection of early metastases Expert Rev. Mol. Diagn. 2003, 3 (3) 303-330 (Pubitemid 36612203)
8. Carlson, J. A.; Slominski, A.; Linette, G. P.; Mihm, M. C., Jr.; Ross, J. S. Biomarkers in melanoma: predisposition, screening and diagnosis Expert Rev. Mol. Diagn. 2003, 3 (2) 163-184 (Pubitemid 36313750)
9. Raposinho, P. D.; Correia, J. D. G.; Oliveira, M. C.; Santos, I. Melanocortin-1 Receptor-Targeting With Radiolabeled Cyclic alpha-Melanocyte- Stimulating Hormone Analogs for Melanoma Imaging Biopolymers 2010, 94 (6) 820-829
10. Haskell-Luevano, C.; Todorovic, A.; Gridley, K.; Sorenson, N.; Irani, B.; Xiang, Z. The melanocortin pathway: effects of voluntary exercise on the melanocortin-4 receptor knockout mice and ACTH(1-24) ligand structure activity relationships at the melanocortin-2 receptor Endocr. Res. 2004, 30 (4) 591-597 (Pubitemid 40070136)
11. Holder, J. R.; Haskell-Luevano, C. Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies Med. Res. Rev. 2004, 24 (3) 325-356 (Pubitemid 38490035)
12. Garcia-Borron, J. C.; Sanchez-Laorden, B. L.; Jimenez-Cervantes, C. Melanocortin-1 receptor structure and functional regulation Pigment Cell Res. 2005, 18 (6) 393-410 (Pubitemid 41691455)
13. Al-Obeidi, F.; Castrucci, A. M.; Hadley, M. E.; Hruby, V. J. Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics J. Med. Chem. 1989, 32 (12) 2555-2561 (Pubitemid 20002805)
14. Dorr, R. T.; Lines, R.; Levine, N.; Brooks, C.; Xiang, L.; Hruby, V. J.; Hadley, M. E. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study Life Sci. 1996, 58 (20) 1777-1784 (Pubitemid 26148611)
15. 10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors J. Med. Chem. 1995, 38 (18) 3454-3461
16. Nijenhuis, W. A. J.; Wanders, N.; Kruijtzer, J. A. W.; Liskamp, R. M.; Gispen, W. H.; Adan, R. A. H. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides Eur. J. Pharmacol. 2004, 495 (2-3) 145-152 (Pubitemid 38891871)
17. Mayorov, A. V.; Han, S. Y.; Cai, M.; Hammer, M. R.; Trivedi, D.; Hruby, V. J. Effects of macrocycle size and rigidity on melanocortin receptor-1 and -5 selectivity in cyclic lactam alpha-melanocyte-stimulating hormone analogs Chem. Biol. Drug Des. 2006, 67 (5) 329-335
18. Grieco, P.; Cai, M.; Liu, L.; Mayorov, A.; Chandler, K.; Trivedi, D.; Lin, G.; Campiglia, P.; Novellino, E.; Hruby, V. J. Design and microwave-assisted synthesis of novel macrocyclic peptides active at melanocortin receptors: discovery of potent and selective hMC5R receptor antagonists J. Med. Chem. 2008, 51 (9) 2701-2707 (Pubitemid 351620792)
19. 99mTc, Re): Synthesis, characterization, and biological behavior Bioconjugate Chem. 2005, 16 (2) 438-449 (Pubitemid 40388220)
20. Correia, J. D.; Paulo, A.; Santos, I. Re and Tc Complexes with Pyrazolyl-Containing Chelators: from Coordination Chemistry to Target-Specific Delivery of Radioactivity Curr. Radiopharm. 2009, 2 (4) 277-294
21. Alves, S.; Correia, J. D. G.; Santos, I.; Veerendra, B.; Sieckman, G. L.; Hoffman, T. J.; Rold, T. L.; Figueroa, S. D.; Retzloff, L.; McCrate, J.; Prasanphanich, A.; Smith, C. J. Pyrazolyl conjugates of bombesin: a new tridentate ligand framework for the stabilization of fac-[M(CO)(3)](+) moiety Nucl. Med. Biol. 2006, 33 (5) 625-634 (Pubitemid 44037434)
22. 3-labeled pyrazolyl-alpha-melanocyte-stimulating hormone analog conjugate for melanoma targeting Nucl. Med. Biol. 2008, 35 (1) 91-99
23. +: effect of cyclization on tumor-seeking properties J. Biol. Inorg. Chem. 2008, 13 (3) 449-459
24. Grieco, P.; Campiglia, P.; Gomez-Monterrey, I.; Lama, T.; Novellino, E. Rapid and efficient methodology to perform macrocyclization reactions in solid-phase peptide chemistry Synlett 2003, 14, 2216-2218 (Pubitemid 37430794)
25. Oliveira, B. L.; Correia, J. D.; Raposinho, P. D.; Santos, I.; Ferreira, A.; Cordeiro, C.; Freire, A. P. Re and (99m)Tc organometallic complexes containing pendant l-arginine derivatives as potential probes of inducible nitric oxide synthase Dalton Trans. 2009, 1, 152-162
26. 3 Dalton Trans. 2012, 41 (10) 2950-2958
27. 3 radiopharmaceuticals: attack of a terminal amine on coordinated acetonitrile Inorg. Chem. 2010, 49 (5) 2123-2131
28. Elipe, M. V. S.; Mosley, R. T.; Bednarek, M. A.; Arison, B. H. H-1-NMR studies on a potent and selective antagonist at human melanocortin receptor 4 (hMC-4R) Biopolymers 2003, 68 (4) 512-527 (Pubitemid 36427876)
29. Cho, M. K.; Lee, C. J.; Lee, C. H.; Li, S. Z.; Lim, S. K.; Baik, J. H.; Lee, W. Structure and function of the potent cyclic and linear melanocortin analogues J. Struct. Biol. 2005, 150 (3) 300-308 (Pubitemid 40693680)
30. Ying, J.; Kover, K. E.; Gu, X.; Han, G.; Trivedi, D. B.; Kavarana, M. J.; Hruby, V. J. Solution structures of cyclic melanocortin agonists and antagonists by NMR Biopolymers 2003, 71 (6) 696-716 (Pubitemid 38325780)
31. + J. Am. Chem. Soc. 2001, 123 (13) 3135-3136 (Pubitemid 32884177)
32. 2Br] Inorg. Chem. Commun. 2004, 7 (9) 1023-1026
33. 99mTc(I)-labeled homobivalent alpha-melanocyte-stimulating hormone analogs for melanocortin-1 receptor targeting J. Biol. Inorg. Chem. 2012, 4, 491-505
34. Mirassou, Y.; Santiveri, C. M.; de Vega, M. J. P.; Gonzalez-Muniz, R.; Jimenez, M. A. Disulfide Bonds versus Trp center dot center dot center dot Trp Pairs in Irregular beta-Hairpins: NMR Structure of Vammin Loop 3-Derived Peptides as a Case Study ChemBioChem 2009, 10 (5) 902-910
35. TOPSPIN, p., NMR Data Acquisition and Processing Software; Bruker Biospin, Karlsruhe, Germany.
36. 15N chemical shift referencing in biomolecular NMR J. Biomol. NMR 1995, 6 (2) 135-140
37. Wuthrich, K. NMR of proteins and nucleic acids; Wiley: New York, 1986.
38. 99mTc(I) tricarbonyl complex potentially useful as bone-seeking agent: synthesis and biological evaluation J. Biol. Inorg. Chem. 2007, 12 (5) 667-679 (Pubitemid 46870906)
39. Goddard, T. D.; Kneller, D. G. SPARKY 3; University of California, San Francisco, 1999.
40. Guntert, P.; Mumenthaler, C.; Wuthrich, K. Torsion angle dynamics for NMR structure calculation with the new program DYANA J. Mol. Biol. 1997, 273 (1) 283-298 (Pubitemid 27460230)
41. Güntert, P. Automated NMR Protein Structure Calculation Prog. Nucl. Magn. Reson. Spectrosc. 2003, 43, 105
42. Koradi, R.; Billeter, M.; Wuthrich, K. MOLMOL: a program for display and analysis of macromolecular structures J. Mol. Graph. 1996, 14 (1) 51-55 (Pubitemid 26152976)
43. Froidevaux, S.; Calame-Christe, M.; Tanner, H.; Eberle, A. N. Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: Structural parameters affecting tumor uptake and kidney uptake J. Nucl. Med. 2005, 46 (5) 887-895
44. Troutner, D. E.; Volkert, W. A.; Hoffman, T. J.; Holmes, R. A. A neutral lipophilic complex of 99mTc with a multidentate amine oxime Int. J. Appl. Radiat. Isot. 1984, 35 (6) 467-470 (Pubitemid 14111719)